- Home
- / Tenaya Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Tenaya Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$2
2024-10-29
Market Capitalization
$154.6 M
2024-10-29
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|
| General and administrative expense | 18.4M | 31.1M | 33.2M | 29.2M | 24.7M |
| Operating expense total | 125.6M | 115.9M | 93.3M | ||
| EBIT | (72.8M) | (125.6M) | (131.2M) | (115.9M) | (93.3M) |
| Interest income | 108.0K | 2.0M | 7.1M | 4.7M | 2.7M |
| Pre tax profit | (72.7M) | (123.7M) | (124.1M) | (111.1M) | (90.6M) |
| Net Income | (72.7M) | (123.7M) | (124.1M) | (111.1M) | (90.6M) |
| EPS | (2.8) | (1.0) | (1.3) | (0.6) |